First Patients Enrolled in The SIros™ Lateral Sacroiliac Joint Fusion Study

Genesys Spine announced today the first two patients have been enrolled in the prospective SIros™ Lateral Sacroiliac Fusion Study. Dr. Tyler Ptacek, Rapid City, S. Dak. and Dr. Douglas Beall, Oklahoma City, Okla., were the first physicians in the study to enroll patients. This clinical study will be conducted across four centers in the United States.

Genesys Spine Partners with PRIA Healthcare to Improve Patient Coverage

To assist with patient reimbursement solutions, Austin-based medical device manufacturer Genesys Spine is partnering with PRIA Healthcare. The partnership focuses on improving patient reimbursement for Genesys Spine’s SIros™ and SIrten™ SI joint fusion systems.

Record year for Genesys Spine SI Joint Division

Medical device manufacturer Genesys Spine announced today that its SI Joint Division exceeded 2021 sales targets with 184 percent growth over 2020.